Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases

Maria Loiarro, Grazia Gallo, Nicola Fantò, Rita De Santis, Paolo Carminati, Vito Ruggiero, Claudio Sette

Research output: Contribution to journalArticle

Abstract

MyD88 couples the activation of the Toll-like receptors and interleukin-1 receptor superfamily with intracellular signaling pathways. Upon ligand binding, activated receptors recruit MyD88 via its Toll-interleukin-1 receptor domain. MyD88 then allows the recruitment of the interleukin-1 receptor-associated kinases (IRAKs). We performed a site-directed mutagenesis of MyD88 residues, conserved in death domains of the homologous FADD and Pelle proteins, and analyzed the effect of the mutations on MyD88 signaling. Our studies revealed that mutation of residues 52 (MyD88E52A) and 58 (MyD88Y58A) impaired recruitment of both IRAK1 and IRAK4, whereas mutation of residue 95 (MyD88K95A) only affected IRAK4 recruitment. Since all MyD88 mutants were defective in signaling, recruitment of both IRAKs appeared necessary for activation of the pathway. Moreover, overexpression of a green fluorescent protein (GFP)-tagged mini-MyD88 protein (GFP-MyD88-(27-72)), comprising the Glu52 and Tyr58 residues, interfered with recruitment of both IRAK1 and IRAK4 by MyD88 and suppressed NF-κB activation by the interleukin-1 receptor but not by the MyD88-independent TLR3. GFP-MyD88-(27-72) exerted its effect by titrating IRAK1 and suppressing IRAK1-dependent NF-κB activation. These experiments identify novel residues of MyD88 that are crucially involved in the recruitment of IRAK1 and IRAK4 and in downstream propagation of MyD88 signaling.

Original languageEnglish
Pages (from-to)28093-28103
Number of pages11
JournalJournal of Biological Chemistry
Volume284
Issue number41
DOIs
Publication statusPublished - Oct 9 2009

Fingerprint

Interleukin-1 Receptors
Interleukin-1 Receptor-Associated Kinases
Green Fluorescent Proteins
Phosphotransferases
Chemical activation
Mutation
Toll-Like Receptor 1
Myeloid Differentiation Factor 88
Site-Directed Mutagenesis
Mutagenesis
Ligands
Death Domain
Proteins
Experiments

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases. / Loiarro, Maria; Gallo, Grazia; Fantò, Nicola; De Santis, Rita; Carminati, Paolo; Ruggiero, Vito; Sette, Claudio.

In: Journal of Biological Chemistry, Vol. 284, No. 41, 09.10.2009, p. 28093-28103.

Research output: Contribution to journalArticle

Loiarro, Maria ; Gallo, Grazia ; Fantò, Nicola ; De Santis, Rita ; Carminati, Paolo ; Ruggiero, Vito ; Sette, Claudio. / Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases. In: Journal of Biological Chemistry. 2009 ; Vol. 284, No. 41. pp. 28093-28103.
@article{e91f7b95ce89441eabd068156bc6b5e4,
title = "Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases",
abstract = "MyD88 couples the activation of the Toll-like receptors and interleukin-1 receptor superfamily with intracellular signaling pathways. Upon ligand binding, activated receptors recruit MyD88 via its Toll-interleukin-1 receptor domain. MyD88 then allows the recruitment of the interleukin-1 receptor-associated kinases (IRAKs). We performed a site-directed mutagenesis of MyD88 residues, conserved in death domains of the homologous FADD and Pelle proteins, and analyzed the effect of the mutations on MyD88 signaling. Our studies revealed that mutation of residues 52 (MyD88E52A) and 58 (MyD88Y58A) impaired recruitment of both IRAK1 and IRAK4, whereas mutation of residue 95 (MyD88K95A) only affected IRAK4 recruitment. Since all MyD88 mutants were defective in signaling, recruitment of both IRAKs appeared necessary for activation of the pathway. Moreover, overexpression of a green fluorescent protein (GFP)-tagged mini-MyD88 protein (GFP-MyD88-(27-72)), comprising the Glu52 and Tyr58 residues, interfered with recruitment of both IRAK1 and IRAK4 by MyD88 and suppressed NF-κB activation by the interleukin-1 receptor but not by the MyD88-independent TLR3. GFP-MyD88-(27-72) exerted its effect by titrating IRAK1 and suppressing IRAK1-dependent NF-κB activation. These experiments identify novel residues of MyD88 that are crucially involved in the recruitment of IRAK1 and IRAK4 and in downstream propagation of MyD88 signaling.",
author = "Maria Loiarro and Grazia Gallo and Nicola Fant{\`o} and {De Santis}, Rita and Paolo Carminati and Vito Ruggiero and Claudio Sette",
year = "2009",
month = "10",
day = "9",
doi = "10.1074/jbc.M109.004465",
language = "English",
volume = "284",
pages = "28093--28103",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "41",

}

TY - JOUR

T1 - Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases

AU - Loiarro, Maria

AU - Gallo, Grazia

AU - Fantò, Nicola

AU - De Santis, Rita

AU - Carminati, Paolo

AU - Ruggiero, Vito

AU - Sette, Claudio

PY - 2009/10/9

Y1 - 2009/10/9

N2 - MyD88 couples the activation of the Toll-like receptors and interleukin-1 receptor superfamily with intracellular signaling pathways. Upon ligand binding, activated receptors recruit MyD88 via its Toll-interleukin-1 receptor domain. MyD88 then allows the recruitment of the interleukin-1 receptor-associated kinases (IRAKs). We performed a site-directed mutagenesis of MyD88 residues, conserved in death domains of the homologous FADD and Pelle proteins, and analyzed the effect of the mutations on MyD88 signaling. Our studies revealed that mutation of residues 52 (MyD88E52A) and 58 (MyD88Y58A) impaired recruitment of both IRAK1 and IRAK4, whereas mutation of residue 95 (MyD88K95A) only affected IRAK4 recruitment. Since all MyD88 mutants were defective in signaling, recruitment of both IRAKs appeared necessary for activation of the pathway. Moreover, overexpression of a green fluorescent protein (GFP)-tagged mini-MyD88 protein (GFP-MyD88-(27-72)), comprising the Glu52 and Tyr58 residues, interfered with recruitment of both IRAK1 and IRAK4 by MyD88 and suppressed NF-κB activation by the interleukin-1 receptor but not by the MyD88-independent TLR3. GFP-MyD88-(27-72) exerted its effect by titrating IRAK1 and suppressing IRAK1-dependent NF-κB activation. These experiments identify novel residues of MyD88 that are crucially involved in the recruitment of IRAK1 and IRAK4 and in downstream propagation of MyD88 signaling.

AB - MyD88 couples the activation of the Toll-like receptors and interleukin-1 receptor superfamily with intracellular signaling pathways. Upon ligand binding, activated receptors recruit MyD88 via its Toll-interleukin-1 receptor domain. MyD88 then allows the recruitment of the interleukin-1 receptor-associated kinases (IRAKs). We performed a site-directed mutagenesis of MyD88 residues, conserved in death domains of the homologous FADD and Pelle proteins, and analyzed the effect of the mutations on MyD88 signaling. Our studies revealed that mutation of residues 52 (MyD88E52A) and 58 (MyD88Y58A) impaired recruitment of both IRAK1 and IRAK4, whereas mutation of residue 95 (MyD88K95A) only affected IRAK4 recruitment. Since all MyD88 mutants were defective in signaling, recruitment of both IRAKs appeared necessary for activation of the pathway. Moreover, overexpression of a green fluorescent protein (GFP)-tagged mini-MyD88 protein (GFP-MyD88-(27-72)), comprising the Glu52 and Tyr58 residues, interfered with recruitment of both IRAK1 and IRAK4 by MyD88 and suppressed NF-κB activation by the interleukin-1 receptor but not by the MyD88-independent TLR3. GFP-MyD88-(27-72) exerted its effect by titrating IRAK1 and suppressing IRAK1-dependent NF-κB activation. These experiments identify novel residues of MyD88 that are crucially involved in the recruitment of IRAK1 and IRAK4 and in downstream propagation of MyD88 signaling.

UR - http://www.scopus.com/inward/record.url?scp=70350496589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350496589&partnerID=8YFLogxK

U2 - 10.1074/jbc.M109.004465

DO - 10.1074/jbc.M109.004465

M3 - Article

C2 - 19679662

AN - SCOPUS:70350496589

VL - 284

SP - 28093

EP - 28103

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 41

ER -